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The effects of the cholinoceptor agonist, carbachol (CCh), were examined in the rat hippocampal slice 
preparation. Intracellular recordings from CA 1 pyramidal neurones revealed that CCh (1-3/~M) inhibited 
excitatory postsynaptic responses evoked by stimulation of the Schaffer collateral/commissural pathway 
while, at the same time, direct excitability was enhanced. Extracellularly, CCh produced a concentration- 
dependent reduction of the amplitude of the field excitatory postsynaptic potential (field EPSP) recorded 
in the CAI apical dendritic region. The muscarinic receptor antagonist, pirenzepine, competitively antago- 
nized the effects of CCh on the field EPSP with a pA2 of 7.4. These results confirm earlier reports of a 
presynaptic nhibitory action of CCh in the hippocampal CAI region and provide strong evidence that 
this effect is mediated by muscarinic receptors of the Mt subtype. 
The classification of muscarinic receptors into two broad categories on the basis 
of their high (M0 and low (M2) affinities for the antagonist, pirenzepine [9], has 
prompted a number of attempts to establish the subtypes mediating the electrophy- 
siological responses to muscarinic agonists throughout the brain [4-6, 14-16, 19]. In 
hippocampal CA I pyramidal neurones, both the membrane depolarization and 
blockade of IAHp induced by carbachol (CCh) have been attributed to an action at 
M1 receptors, whereas inhibition of the M-current may result from M2 receptor activa- 
tion [4]. In addition to these postsynaptic effects, muscarinic agonists can also reduce 
the synaptically-evoked excitation of CA 1 neurones by a presynaptic mechanism [11, 
18]. Unfortunately, attempts to classify this latter response in terms of receptor sub- 
type have yielded conflicting reports: both M2 [4] and Mi [16] receptors have been 
implicated. However, since neither of these arlier studies employed formal quantita- 
tive pharmacological procedures, conclusions from them must remain tentative. We 
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Fig. 1. Intracellular recordings from a single CA1 pyramidal neurone (RMP = -66 mV). A: CCh (3/tM) 
reversibly reduced the EPSC evoked by electrical stimulation of the SCC pathway (holding potential, 
VH = --70 mV). To facilitate comparisons of the EPSCs in the absence and presence ofdrug, the small 
inward current induced by CCh has been subtracted from the centre trace. B: effect of CCh (3/~M) on 
spike trains generated bydepolarizing current injection (0.15 nA, 300 ms). During drug application, the 
membrane potential was manually clamped to -66 mV to compensate for the small depolarization 
induced by CCh in this cell (5 mV). Note the reversible enhancement by CCh of discharge frequency to- 
gether with a reduction of the afterhyperpolarization. Records in B were obtained immediately after the 
corresponding voltage-clamp measurements shown in A. 
have therefore re-examined the identity of the presynaptic muscarinic receptor under- 
lying inhibition of excitatory transmission i CA 1 using full Schild analysis [2] of the 
antagonistic effects of pirenzepine on the CCh-induced suppression of the field exci- 
tatory postsynaptic potential (EPSP). 
Transverse slices of hippocampus (thickness 500/~m), prepared from adult male 
Sprague-Dawley rats, were stored in an artificial cerebrospinal fluid (CSF) contain- 
ing (in mM): NaC1 124, KC1 5, CaCI2 2.5, MgSO4 2, NaHzPO4 1.25, NaHCO3 22, 
D-glucose 10, gassed at room temperature with 95% 02/5% CO2. After at least 1 h, 
one slice was transferred to the recording chamber and submerged in continuously 
flowing artificial CSF at 30-33°C. A concentric stimulation electrode, placed in the 
Schaffer collateral/commissural (SCC) pathway, was used to evoke synaptic excita- 
tion of neurones in area CA1 (stimulation frequency: 0.05 Hz). For the intracellular 
experiments glass electrodes containing 4 M potassium acetate (pH 7.2; resistance 
60-90 MQ) were used. Voltage-clamp measurements of excitatory postsynaptic cur- 
rents (EPSCs) were made using a switched current- and voltage-clamp amplifier (npi 
SEC I L, switching frequency 18-20 kHz, 25 % duty cycle) (see Ref. 17). To minimize 
contamination of EPSCs by inhibitory inputs, synaptic urrents evoked by low stim- 
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ulation intensities were recorded at a holding potential (VH) corresponding to the 
reversal potential of the y-aminobutyric a id A (GABAg)-mediated, chloride-depen- 
dent inhibitory postsynaptic current (IPSC; -67 to -72 mV) [1]. At this potential 
the amplitude of the IPSC should be negligible. A late, potassium-dependent IPSC 
was not observed at the low stimulation i tensities used. For the extracellular experi- 
ments glass micropipettes containing 4 M NaC1 (resistance 2-5 Mr2) were used to 
record field EPSPs in the apical dendritic region of area CAl. Care was taken to ad- 
just the stimulation current so that the field EPSPs were free from contaminating 
population spikes. Cumulative dose-response curves to CCh were constructed for 
each slice, allowing 15 rain equilibration at each concentration. Following comple- 
tion of the control dose-response curve, the slice was superfused with drug-free sol- 
ution for 30 min. (Only slices in which the field EPSP amplitude returned to within 
+ 5% of the initial control value were included in subsequent antagonism studies.) 
The slice was then superfused with pirenzepine (0.1, 0.3 or 1/~M) for 45 min, after 
which the dose-response curve to CCh was repeated. Only one antagonist concentra- 
tion was applied to each slice. Concentration-response curves were fitted by non-lin- 
ear regression (weighted by actual distance). Antagonism data were analysed by the 
method of Arunlakshana and Schild [2], dose-ratios being derived for each slice and 
then pooled. Grouped ata are expressed as mean _+ S.E.M. 
Firstly, the effects of CCh on the excitability of single CA 1 neurones (resting mem- 
brane potential, RMP >-65  mV, input resistance > 50 MQ; n=4) were investi- 
gated. In agreement with others, CCh (1-3 pM) induced small membrane depolariza- 
tions (5-8 mV), increased input resistance (9-15 %), blocked the adaptation of firing 
seen during prolonged epolarizing current injection and reduced the afterhyperpo- 
larization associated with a spike train. In contrast, synaptically-driven responses 
were attenuated: both EPSPs and excitatory postsynaptic currents (EPSCs) evoked 
by low intensity stimulation of the SCC pathway were reversibly reduced. An exam- 
ple of the action of CCh on one cell is shown in Fig. 1. 
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Fig. 2. Concentration-dependent r duction of the extracellularly recorded field EPSP by CCh in a single 
slice in the absence (A) and presence (B) of pirenzepine (0.3 gM). CCh concentrations (,uM) are shown 
above the traces (averages of 3-5 sweeps). CCh was applied cumulatively (see text) and the records taken 
at 15 min following the start of each application. Arrows signify point of electrical stimulation. 
276 
A 
17 
CO 
C1_ 
w 
o2 
c 
1"I3 
g~ 
100 
50 
i , ~ , r i , i 
i i i 
-7 -6 -5 -4 
log ItCh] M 
-3 
B 
l 
CD 
o 
cn  
o 
0 
/ 
/ - /  
/ 
J /J 
/ pA 2 : 7.38 
-7 6 
log [pinenzepinel W 
Fig. 3. A: pooled concentration-response curves to CCh in the absence (O) and presence of 0.1 (0), 0.3 
(A) and 1.0 #M ( I )  pirenzepine. Each curve was obtained from 3 to 12 slices (correlation coefficient 
r >10.998 in each case). B: Schild plot for the antagonism by pirenzepine of the effects of CCh on the 
field EPSP (r =0.998). 
Superfusion of slices with CCh (0.1-3 #M) produced consistent, non-desensitizing 
reductions in the amplitude of the field EPSP: responses were stable after 10-12 min 
of drug application and readily reversible upon wash-out. A cumulative dosing sche- 
dule was therefore adopted in subsequent experiments, allowing 15 min at each con- 
centration of CCh before progressing to the next. An example of the effect of CCh 
on the field EPSP from a single slice is shown in Fig. 2 and a summary from all slices 
studied is shown in Fig. 3A (control curve; ECs0 = 1.43+0.15 #M; n= 12). 
In the final series of experiments he antagonistic effects of pirenzepine on the 
CCh-induced epression of the field EPSP were studied. Pirenzepine (0.1, 0.3 or I 
MM) produced parallel rightward isplacements of the CCh concentration-response 
curve (Fig. 3A). A Schild plot constructed from these data is shown in Fig. 3B 
(pA2 = 7.38 ___ 0.06; slope = 1.03 + 0.04). 
In confirmation of earlier eports [11, 18], the present data provide evidence that 
CCh is able to depress excitatory synaptic transmission i the SCC/CAI pathway 
by a presynaptic mechanism. Thus, although the direct excitability of CAI neurones 
was enhanced by CCh, synaptically-evoked r sponses (EPSC and EPSP) were consis- 
tently depressed. That this latter action was mediated at a presynaptic locus is consid- 
erably strengthened by the fact that input resistance was invariably increased by 
CCh, an effect which would tend to potentiate synaptically-driven r sponses rather 
than diminish them. Extracellularly, CCh induced aconcentration-dependent, piren- 
zepine-sensitive r duction of the amplitude of the field EPSP. The pA2 value of 7.38 
for the antagonism by pirenzepine of this depressant action of CCh, is in close agree- 
ment with recent binding data for the interaction of pirenzepine with both cortical 
(pKi = 7.7; [7]) and hippocampal (pKi = 7.43; [3]) M1 receptors labelled with [3H]pir- 
enzepine. 
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That  this presynaptic holinergic mechanism may have some physiological  rele- 
vance is supported by a recent report  from Herreras et al. [10], who found that the 
potent inhibitory effect of  sensory st imulat ion on SCC pathway-evoked CA1 field 
potentials in the anaesthetized rat was completely abol ished by muscarinic, but not 
by GABAergic ,  antagonists. The morphological  basis for a cholinergic innervation 
of  the apical dendrit ic region of  area CA I is already firmly established [12]. 
In conclusion, our findings provide strong evidence that the presynaptic muscari-  
nic receptor mediat ing depression of  synaptic transmission in the SCC pathway is 
of  the MI subtype. In this respect it is interesting that Wil l iams and Constant i  [19], 
using similar pharmacological  techniques, have attr ibuted the muscarinic depression 
of  the synaptical ly-evoked potential  in the olfactory cortex slice preparat ion also to 
an action at presynaptic M~ receptors. 
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